Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Global estimates indicated 2.3 million new cases of breast cancer in 2020, contributing to nearly 12% of all new cancer cases, with 685 000 deaths in the same year.1 Breast cancer detection has increased due to improvements in screening techniques. The mortality rate […]
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
Recommendations for the use of next-generation sequencing (NGS) Considering the evolving field of drug development and genomic data, the European Society for Medical Oncology (ESMO) Precision Medicine Working Group (PMWG) sought to update recommendations for the use f next-generationsequencing (NGS) for patients with metastatic cancers published in 2020. After several discussions among the members of […]
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline Hereditary breast and ovarian cancer syndrome (HBOC) is clinically defined by family history criteria, and molecularly defined by identification of germline pathogenic variants (PVs) in clinically validated HBOC genes.1 These genes are broadly classified as high-risk genes, increasing breast and […]
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer Metastatic breast cancer (MBC) is an incurable disease, but survival improvements have been reported with appropriate therapeutic strategies.1-8 Systemic therapy standard-of-care in MBC but may be supplemented with locoregional treatments (LRTs)according to the disease status of the individual patient. […]
تیم ملی اسکواش ایران در کمپین پیشگیری از سرطان
تیم ملی اسکواش ایران در کمپین پیشگیری از سرطان https://gliomed.ir/wp-content/uploads/2024/12/video_2024-12-16_19-00-05.mp4 حفظ تناسب اندام و کاهش اضافه وزن ریسک ابتلا به سرطان رو کاهش میده برای بزرگسالان حداقل ۱۵۰-۳۰۰ دقیقه فعالیت بدنی با شدت متوسط و یا ۷۵-۱۵۰ دقیقه فعالیت بدنی شدید در هفته توصیه می شود. برای کودکان و نوجوانان، حداقل یک ساعت فعالیت فیزیکی شدید یا […]
کنگره بینالمللی کنسرژنومیکس
برگزاری دومین کنگره بینالمللی کنسرژنومیکس
دکتر داریوش فرهود
متخصص ژنتیک پزشکی
دکتر امین جهان بخشی
جراح مغز و اعصاب و ستون فقرات
دکتر امینه سادات واقفی
متخصص پاتولوژی ، مشاور ژنتیک سرطان